Molecular Cancer Therapeutics
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
Journal Specifications
- PublisherAMER ASSOC CANCER RESEARCH
- LanguageEnglish
- FrequencyMonthly
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year2002
- Publisher URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Molecular Cancer Therapeutics been publishing? 
The Molecular Cancer Therapeutics has been publishing since 2002 till date.
How frequently is the Molecular Cancer Therapeutics published?
Molecular Cancer Therapeutics is published Monthly.
What is the H-index. SNIP score, Citescore and SJR of Molecular Cancer Therapeutics?
Molecular Cancer Therapeutics has a H-index score of 190, Citescore of 10.2, SNIP score of 1.21, & SJR of Q1
Who is the publisher of Molecular Cancer Therapeutics?
The publisher of Molecular Cancer Therapeutics is AMER ASSOC CANCER RESEARCH.
How can I view the journal metrics of Molecular Cancer Therapeutics on editage?
For the Molecular Cancer Therapeutics metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Molecular Cancer Therapeutics?
The eISSN number is 1538-8514 and pISSN number is 1535-7163 for Molecular Cancer Therapeutics.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Cancer, Antigen, Mutant, Lung cancer, Extracellular matrix, Head and neck, Immunotherapy, Tyrosine kinase, Breast cancer, Camptothecin, Gemcitabine, Radiation, Glioblastoma, Oxidative stress, Cell cycle, Antitumor activity, DNA damage, Monoclonal antibody, Lymphoma, Homologous recombination.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.